Anaerobic Bacterial Infection

Also known as: Anaerobic bacterial infection NOS / Infection caused by anaerobic bacteria (disorder)

Drug	Drug Name	Drug Description
DB00916	Metronidazole	A nitroimidazole used to treat trichomoniasis, amebiasis, inflammatory lesions of rosacea, and bacterial infections, as well as prevent postoperative infections.
DB13026	Ornidazole	A nitroimidazole agent indicated in the treatment of infections such as trichomoniasis, amebiasis, and giardiasis.

Drug	Drug Name	Target	Type
DB00916	Metronidazole	Oxygen-insensitive NADPH nitroreductase	target
DB00916	Metronidazole	Cytochrome P450 2C9	enzyme
DB00916	Metronidazole	Cytochrome P450 3A4	enzyme
DB00916	Metronidazole	Cytochrome P450 2C8	enzyme
DB00916	Metronidazole	UDP-glucuronosyltransferase 1-1	enzyme
DB00916	Metronidazole	Anaerobic bacterial DNA	target
DB00916	Metronidazole	Protozoal DNA	target
DB00916	Metronidazole	P-glycoprotein 1	transporter
DB00916	Metronidazole	Cytochrome P450 2A6	enzyme
DB00916	Metronidazole	Cytochrome P450 3A5	enzyme
DB00916	Metronidazole	Cytochrome P450 3A7	enzyme

Drug	Drug Name	Phase	Status	Count